GLENN JOHN 4
4 · IRADIMED CORP · Filed Apr 4, 2025
Insider Transaction Report
Form 4
IRADIMED CORPIRMD
GLENN JOHN
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2024-06-20+5,796→ 10,179 total - Exercise/Conversion
Restricted Stock Units
2024-06-20+5,796→ 11,592 totalFrom: 2024-06-20→ Common Stock (5,796 underlying) - Tax Payment
Common Stock
2024-06-20$42.53/sh−1,412$60,052→ 8,767 total
Footnotes (3)
- [F1]Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units ("RSUs") on a one-for-one basis.
- [F2]The transaction was inadvertently reported late. The aggregate amount of securities beneficially owned includes the delinquent transaction plus all transactions reported in Form 4's filed after the date of the delinquent transaction.
- [F3]The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.